Medtronic plc announced that the US Food and Drug Administration (FDA) has approved its Percept? RC deep brain stimulation system (DBS). The rechargeable neurostimulator is the latest innovation in the Percept?
family, why also the Percept? PC neurostimulator, BrainSense?? technology+ and SenSight?
directional distractions. The Percept?? family is the only sensor-driven DBS system on the market, allowing the clinician to personalize treatment for patients with movement disorders such as Parkinson’s disease, essential tremor, dystonia* and epilepsy.
More than 11 million people in the US live with movement disorders1-2 and approximately 3.4 million with epilepsy3. DBS uses a surgically implanted medical device, similar to a pacemaker. Medtronic Percept?®?
neurostimulators send electrical signals through thin wires to specific brain targets affected by debilitating neurological conditions such as Parkinson’s disease. Perception? RC is the smallest and thinnest dual-channel++ neurostimulator available for DBS.
It is equipped with BrainSense? technology that captures and records brain signals to provide insights that allow a healthcare provider to adapt and personalize therapy to the patient’s changing needs. Unlike other rechargeable devices, the Percept?
RC battery has a lifespan of at least 15 years with consistent and fast charging performance. Medtronic’s patented battery technology has less battery fade than other rechargeable devices for a more reliable, long-lasting battery.SS Patients can be quickly charged from 10% to 90% full charge in less than an hour. It is estimated that almost 70% of all patients eligible for DBS require an MRI as part of their essential care4.
Medtronic was the first in the United States to offer conditional whole-body MR systems that allow patients to obtain safe scans anywhere on the body under specific conditions++. Perception?? provides greater freedom and scanning access for patients with 3T scans and best-in-class 1.5T MRI scan labeling5-7. In addition, the Percept?
neurostimulators designed so that future software updates designed for the Percept?? platform are possible without having to replace the neurostimulator device.
2024-01-08 17:38:00
#Medtronic #plc #announces #FDA #approval #Percept #deep #brain #stimulation #system
